Knockdown of BAG3 induces epithelialmesenchymal transition in thyroid cancer cells through ZEB1 activation

Cell Death and Disease

Volumn 5, Issue 2, 2014, Pages

  Meng, X ^a   Kong, D H ^a   Li, N ^a   Zong, Z H ^a   Liu, B Q ^a   Du, Z X ^a   Guan, Y ^a   Cao, L ^a   Wang, H Q ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

BAG3; E cadherin; EMT; ZEB1

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN;

ARTICLE; BCL 2 ASSOCIATED ATHANOGENE 3; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; METASTASIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; TRANSACTIVATION; TRANSCRIPTION INITIATION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS REGULATORY PROTEINS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL SHAPE; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

EID: 84896759879     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.32     Document Type: Article

References (32)

1. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Kung AL, Davies FE et al. Antimyeloma activity of heat shock protein-90 inhibition. Blood 2006; 107: 1092-1100.
2. Christofori G. New signals from the invasive front. Nature 2006; 441: 444-450.
3. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
4. Savagner P. Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition. BioEssays 2001; 23: 912-923.
5. Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2009; 1796: 75-90.
6. Bozdogan O, Atasoy P, Bozdogan N, Erekul S, Batislam E, Yilmaz E et al. BAG-1 expression in hyperplastic and neoplastic prostate tissue: Is there any relationship with BCL-related proteins and androgen receptor status? Tumori 2005; 91: 539-545.
7. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
8. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metast Rev 2009; 28: 151-166.
9. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004; 48: 365-375.
10. Lee JH, Takahashi T, Yasuhara N, Inazawa J, Kamada S, Tsujimoto Y. Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 1999; 18 6190.
11. Takayama S, Xie Z, Reed JC. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 1999; 274: 781-786.
12. Doong H, Price J, Kim YS, Gasbarre C, Probst J, Liotta LA et al. CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. Oncogene 2000; 19: 4385-4395.
13. Festa M, Del Valle L, Khalili K, Franco R, Scognamiglio G, Graziano V et al. BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol 2011; 178: 2504-2512.
14. Romano MF, Festa M, Petrella A, Rosati A, Pascale M, Bisogni R et al. BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol Ther 2003; 2: 508-510.
15. Romano MF, Festa M, Pagliuca G, Lerose R, Bisogni R, Chiurazzi F et al. BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ 2003; 10 385.
16. Chiappetta G, Ammirante M, Basile A, Rosati A, Festa M, Monaco M et al. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Clin Endocrinol Metab 2007; 92: 1159-1163.
17. Rosati A, Bersani S, Tavano F, Dalla Pozza E, De Marco M, Palmieri M et al. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. Am J Pathol 2012; 181: 1524-1529.
18. Franco R, Scognamiglio G, Salerno V, Sebastiani A, Cennamo G, Ascierto PA et al. Expression of the anti-Apoptotic protein BAG3 in human melanomas. J Invest Dermatol 2012; 132: 252-254.
19. Du ZX, Meng X, Zhang HY, Guan Y, Wang HQ. Caspase-dependent cleavage of BAG3 in proteasome inhibitors-induced apoptosis in thyroid cancer cells. Biochem Biophys Res Commun 2008; 369: 894-898.
20. Villard E, Perret C, Gary F, Proust C, Dilanian G, Hengstenberg C et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 2011; 32: 1065-1076.
21. Du ZX, Zhang HY, Meng X, Gao YY, Zou RL, Liu BQ et al. Proteasome inhibitor MG132 induces BAG3 expression through activation of heat shock factor 1. J Cell Physiol 2009 631-637.
22. Suzuki M, Iwasaki M, Sugio A, Hishiya A, Tanaka R, Endo T et al. BAG3 (BCL2-Associated athanogene 3 interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett 2011; 303: 65-71.
23. Chiappetta G, Basile A, Arra C, Califano D, Pasquinelli R, Barbieri A et al. BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasomemediated degradation of BRAF protein. J Clin Endocrinol Metab 2012; 97: E115-E120.
24. Kong DH, Zhang Q, Meng X, Zong ZH, Li C, Liu BQ et al. BAG3 sensitizes cancer cells exposed to DNA damaging agents via direct interaction with GRP78. Biochim Biophys Acta 2013; 1833: 3245-3253.
25. Iwasaki M, Homma S, Hishiya A, Dolezal SJ, Reed JC, Takayama S. BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer Res 2007; 67: 10252-10259.
26. Kassis JN, Guancial EA, Doong H, Virador V, Kohn EC. CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res 2006; 312: 2962-2971.
27. Iwasaki M, Tanaka R, Hishiya A, Homma S, Reed JC, Takayama S. BAG3 directly associates with guanine nucleotide exchange factor of Rap1, PDZGEF2, and regulates cell adhesion. Biochem Biophys Res Commun 2010; 400: 413-418.
28. Li N, Du ZX, Zong ZH, Liu BQ, Li C, Zhang Q et al. PKCdelta-mediated phosphorylation of BAG3 at Ser187 site induces epithelial-mesenchymal transition and enhances invasiveness in thyroid cancer FRO cells. Oncogene 2013; 32: 4539-4548.
29. Sanchez-Tillo E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A. Beta-catenin/TCF4 complex induces the epithelial-To-mesenchymal transition (EMT)-Activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci USA 2011; 108 19209.
30. Brabletz S, Brabletz T. The ZEB/miR-200 feedback loop-A motor of cellular plasticity in development and cancer? EMBO Rep 2010; 11: 670-677.
31. Sanchez-Tillo E, Siles L, de Barrios O, Cuatrecasas M, Vaquero EC, Castells A et al. Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res 2011; 1: 897-912.
32. Haynes J, Srivastava J, Madson N, Wittmann T, Barber DL. Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. Mol Biol Cell 2011; 22: 4750-4764.